Sage Journals: Discover world-class research

Retricted access

Review article

First published 2022-10

Role of sacituzumab govitecan in solid tumors

Sindhusha Veeraballi, Zaineb Khawar, Hafiz Muhammad Aslam [...]

Journal of Oncology Pharmacy Practice

Retricted access

Review article

First published 2021-7

Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory,Metastatic,Triple-Negative Breast Cancer

John M. Seligson, Alexandra M. Patron, Michael J. Berger [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2023

Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany

Mattea Reinisch, Simona Bruzas, Jennifer Spoenlein [...]

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2025

Exceptional response to TROP2 inhibition with sacituzumab govitecan in a patient with small cell carcinoma of the breast: a case report

Kasey C. Fitzsimmons, Michelle A. Fajardo, Zorawar Noor

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2025-6

Targeted therapy in TNBC: Exploring the role of antibody-drug conjugates with a focus on sacituzumab govitecan

Nahida Siddiqui, Moduru Tejo Arun, Kummari Aparna [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2022-4

Case report of sacituzumab govitecan-hziy-induced neutropenia in a patient with metastatic triple-negative breast cancer and a uridine diphosphate glucuronosyltransferase family 1 member A1 poor metabolizer genotype

Grace Baek, Lindsey Jung, Arianne Duong [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2026

Effectiveness,safety,and biomarker analysis of sacituzumab govitecan in Chinese metastatic breast cancer: a multicenter real-world study

Mu Li, Die Sang, Jin-feng Zhang [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2024-1

Sacituzumab Govitecan as a Second-Line Treatment in Relapsed/Refractory Metastatic Triple-Negative Breast Cancer Patients: A Systematic Review and Meta-analysis

Meghavi Kathpalia, Anurag Sharma, Navkiran Kaur

Annals of Pharmacotherapy

Open access

Research article

First published 2025

Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort

Małgorzata Pienia̧żek, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026

Sacituzumab govitecan in breast cancer patients – an evaluation of progression-free survival,overall survival,and hypersensitivity reactions in real-world patients

Kaitlyn Becker, Christopher Walczak, Jolly Patel

Journal of Oncology Pharmacy Practice

Search results